Comparative effectiveness and toxicity of radiotherapy regimens in limited stage small cell lung cancer: A network meta‐analysis

Comparative effectiveness and toxicity of radiotherapy regimens in limited stage small cell lung cancer: A network meta‐analysis

Abstract Purpose The aim of this Network Meta‐analysis was to compare the current radiotherapy regimens of limited‐stage small cell lung cancer (LS‐SCLC), in terms of overall survival (OS), progression‐free survival (PFS), and the incidence of acute radioactive esophagitis and radioactive pneumonia....

Full description

Bibliographic Details
Main Authors:	Jiupeng Zhou, Hui Guo, Yongfeng Zhang, Heng Liu, Quanli Dou
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Cancer Medicine
Subjects:	effectiveness limited‐stage small cell lung cancer network meta‐analysis radiotherapy regimens toxicity
Online Access:	https://doi.org/10.1002/cam4.4774

Similar Items

Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier
by: Tzen S. Toh, et al.
Published: (2021-12-01)

Thoracic radiotherapy timing and prognostic factors in elderly patients with limited‐stage small cell lung cancer
by: Huan Zhao, et al.
Published: (2024-03-01)

Clinical Efficiency and Safety of Hypofractionated Thoracic Radiotherapy Combined with EP Chemotherapy on Patients with Limited-stage Small-cell Lung Cancer
by: HE Yisheng, et al.
Published: (2023-02-01)

Sequential or concomitant chemotherapy in limited stage small-cell lung cancer
by: K Khanfir, et al.
Published: (2011-05-01)

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study
by: Zhen Jia, et al.
Published: (2023-08-01)

Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and Chemotherapy
by: Jianyang Wang, et al.
Published: (2023-02-01)

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
by: Lijuan Li, et al.
Published: (2023-04-01)

Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?
by: Lin Ma, et al.
Published: (2023-12-01)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
by: Huanhuan Li, et al.
Published: (2023-08-01)

Results of Treatment with Stereotactic Radiotherapy in Patients with Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
by: Cengiz Gemici
Published: (2017-06-01)

Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer
by: Jianfeng Peng, et al.
Published: (2023-07-01)

Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease
by: Naoko Okano, et al.
Published: (2021-08-01)

Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database
by: Deng Chen, et al.
Published: (2021-11-01)

A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC
by: Jessica Imbrescia, et al.
Published: (2022-09-01)

Value of carbon-ion radiotherapy for early stage non-small cell lung cancer
by: Juan Xiong, et al.
Published: (2022-09-01)

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
by: Jing Luo, et al.
Published: (2023-06-01)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
by: Stéphanie L. Mercier, et al.
Published: (2022-12-01)

Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
by: Yuhei Miyasaka, et al.
Published: (2021-01-01)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
by: Bochen Sun, et al.
Published: (2022-11-01)

Radiotherapy for small cell lung cancer in current clinical practice guidelines
by: Haiyan Zeng, et al.
Published: (2022-06-01)

Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada
by: David E. Dawe, et al.
Published: (2023-12-01)

Lung Organotypic Slices Enable Rapid Quantification of Acute Radiotherapy Induced Toxicity
by: Maxime Dubail, et al.
Published: (2023-10-01)

Stereotactic body radiotherapy compared with video‐assisted thoracic surgery after propensity‐score matching in elderly patients with pathologically‐proven early‐stage non‐small cell lung cancer
by: Xiao‐ye Liu, et al.
Published: (2022-12-01)

Survival Outcome after Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis
by: Xiao-Jun Yu, et al.
Published: (2018-09-01)

Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study
by: Yu Chen, et al.
Published: (2022-10-01)

Feasibility and long-term outcomes of post-chemotherapy-based consolidation radiotherapy in extensive stage small-cell lung cancer
by: Chen Jie, et al.
Published: (2023-09-01)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
by: Chang Joe Y, et al.
Published: (2012-09-01)

Protection against Radiotherapy-Induced Toxicity
by: Susan Hall, et al.
Published: (2016-07-01)

Comparing Performances of Predictive Models of Toxicity after Radiotherapy for Breast Cancer Using Different Machine Learning Approaches
by: Maria Giulia Ubeira-Gabellini, et al.
Published: (2024-02-01)

A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non–Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis
by: Shi-Wang Wen, et al.
Published: (2019-01-01)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
by: Hiroshi Onishi, et al.
Published: (2023-09-01)

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study
by: Kazumasa Akagi, et al.
Published: (2022-08-01)

Efficacy and toxicity profile of first‐line treatment for extensive‐stage small cell lung cancer: A Bayesian network meta‐analysis
by: Guo Lin, et al.
Published: (2023-05-01)

The therapeutic effect of radiotherapy combined with systemic therapy compared to radiotherapy alone in patients with simple brain metastasis after first-line treatment of limited-stage small cell lung cancer: a retrospective study
by: Xinyu Gao, et al.
Published: (2024-04-01)

Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy
by: Maria Massaro, et al.
Published: (2022-07-01)

Association between radiotherapy protocol variations and outcome in the CONVERT trial
by: Romaana Mir, et al.
Published: (2023-03-01)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
by: Izabela Zarębska, et al.
Published: (2023-10-01)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
by: Jinfeng Cui, et al.
Published: (2022-05-01)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
by: Chen Yuhchyau, et al.
Published: (2011-06-01)

Progress in radiotherapy for small‐cell lung cancer
by: Fujun Yang, et al.
Published: (2023-09-01)